Trademark: 79371712
Word
SYNKLINO
Status Date
Tuesday, June 11, 2024
Registration Number
7410895
Registration Date
Tuesday, June 11, 2024
Filing Date
Friday, January 6, 2023
Published for Opposition
Tuesday, March 26, 2024
5 Pharmaceutical preparations for the prevention of chronic viral infections in high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for regulating the immune system for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for use in organ transplantation for elimination of chronic viral infections; pharmaceutical preparations for the prevention of diseases of the immune system; immunosuppressants for use following transplantation to prevent graft rejection; pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunotherapeutic agents for treatment of bacterial infections; pharmaceutical preparations for immunity adjustment for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations containing stem cells for high-risk immunocompromised patients and transplant recipients; immunoassay reagents for medical use; pharmaceutical preparations for the treatment of viral diseases; anti-viral agents; protein synthesis inhibitors for high-risk immunocompromised patients and transplant recipients; regulatory proteins being pharmaceutical preparations for medical use for high-risk immunocompromised patients and transplant recipients; pharmaceutical drugs for high-risk immunocompromised patients and transplant recipients; antibacterial pharmaceuticals
10 Surgical apparatus and instruments for medical use; medical diagnostic test instruments for use in immunoanalytical procedures; medical diagnostic testing apparatus for use in medical immunoassay procedures; medical devices for regenerating stem cells for medical purposes; medical apparatus for cell sampling; pharmaceutical instruments and apparatus provided empty used for the inhalation of pharmaceuticals
42 Scientific research; scientific laboratory services; scientific research into stem cells; culturing of cells for scientific research purposes; scientific and medical research services for research and development in the field of immunology; pharmaceutical research; development of pharmaceutical preparations; pharmaceutical research and development services; development of pharmaceutical preparations and medications; carrying out clinical trials for pharmaceutical products; laboratory research on pharmaceutical preparations; consultancy in the field of drug research and development; software as a service (SAAS) services featuring software for gathering, tracking, analyzing and activating data in relation to transformative therapies for high-risk immunocompromised patients and transplant recipients
Jun 8, 2023
Sn Assigned For Sect 66a Appl From Ib
Jun 12, 2023
New Application Office Supplied Data Entered
Jun 16, 2023
Application Filing Receipt Mailed
Sep 29, 2023
Assigned To Examiner
Oct 13, 2023
Non-Final Action Written
Oct 14, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Oct 24, 2023
Refusal Processed By Mpu
Oct 24, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Nov 13, 2023
Refusal Processed By Ib
Feb 19, 2024
Teas Response To Office Action Received
Feb 19, 2024
Correspondence Received In Law Office
Feb 19, 2024
Teas/Email Correspondence Entered
Feb 20, 2024
Approved For Pub - Principal Register
Mar 6, 2024
Notification Of Notice Of Publication E-Mailed
Mar 6, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 26, 2024
Published For Opposition
Mar 26, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 11, 2024
Registered-Principal Register
Jun 11, 2024
Notice Of Registration Confirmation Emailed
Trademark Alertz updated from USPTO on 2030-01-24
